600535.SH
Tasly Pharmaceutical Group Co., Ltd.
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 14.82
−1.00%Forward multiples
Based on analyst estimates
- P/E forward
- 9.97x
- P/E 2026E
- 15.81x
- P/E 2027E
- 13.46x
- P/E 2028E
- 11.69x
- P/S forward
- 2.57x
Trailing multiples
Trailing twelve months
- P/E TTM
- 20.04x
- PEG TTM
- 0.23x
- Price / book
- 1.69x
- Price / sales
- 2.48x
- Price / cash flow
- 9.20x
Enterprise value
- Enterprise value
- CNY 21.3B
- EV / sales
- 2.55x
- EV / EBITDA
- 11.70x
- EV / EBIT
- 15.16x
- Market cap
- CNY 22.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026